EF Hutton Initiates Coverage On FibroBiologics With Buy Rating, Announces Price Target of $16
EF Hutton Initiates Coverage On FibroBiologics With Buy Rating, Announces Price Target of $16
EF Hutton開始對FibroBiologics進行買入評級，宣佈16美元的目標價格。
EF Hutton analyst Jason Kolbert initiates coverage on FibroBiologics (NASDAQ:FBLG) with a Buy rating and announces Price Target of $16.
EF Hutton分析師Jason Kolbert開始對FibroBiologics（納斯達克：FBLG）進行買入評級，並宣佈16美元的目標價格。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。